Per Vaginam and Positron-emission Tomography

The main pharmaco-therapeutic effects: Solution fully human mnoklonalni / t type IgG1k, with high affinity Psoralen UV A specificity for subunits of human r40 interleukins (IL) -12 and IL-23, blocks the biological activity of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not communicate with IL-12 and IL-23, already secretiveness to receptors, so the drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and secretion of cytokines, which are crucial in the development secretiveness psoriasis secretiveness . Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. Dosing and Administration of drugs: used topically in undiluted form as a means of monotherapy or in combination with other drugs; wash infected wounds should be 2 g / day in the disappearance of purulent discharge, and then washing and secretiveness make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound surface every 6 - 8 pm, with the closed method 2 g / day at intervals 6 - 8 hours of burn surface impose bandages soaked much preparation, water the bottom layer bandage without removing it, and these manipulations carried out to complete disappearance of pus, boils and secretiveness of anthrax after opening and evacuation Normoactive Bowel Sounds purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 every 2 - 3 days. The main pharmaco-therapeutic action: active against pyogenic microorganisms: Pseudomonas and enteric rods, however, staphylococci, has low toxicity. Method of production of drugs: emulsion for external use only 20% ointment for external use Per Vaginam cream, 250 mg / g to 40 g or 80 secretiveness Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic Endoscopic Thoracic Sympathectomy due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Indications for use drugs: atopic dermatitis in cases resistant to previous treatment in case of psoriasis resistant to previous treatment. Pharmacotherapeutic group: D08AH10 ** - antiseptics. Dosing and Administration of drugs: treatment should pick up individually for the induction of remission recommended starting dose is 2.5 mg / kg / day in two, in the absence of improvement after 1 month of therapy daily dose can be gradually increased but should not exceed 5 mg / kg, treatment must cease if secretiveness achieved a satisfactory effect of the manifestations of psoriasis after 6 weeks of treatment with a dose of 5 mg / kg / day, or if the effective dose to the defined parameters of safety, the use of the initial dose of 5 mg / kg / day is justified for patients whose condition requires rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and treat relapse following repeated administration of drugs for the previous effective dose, if necessary, supportive therapy dose should reach individually, at secretiveness minimum effective level secretiveness should not exceed 5 mg / kg / day; atopic dermatitis - the recommended starting dose is 2,5-5 mg / kg / day in two, if the initial dose of 2.5 mg / kg per day makes it impossible to achieve a satisfactory effect for 2 weeks, the daily dose to rapidly increase to a maximum of - 5 mg / kg, in very secretiveness cases promptly and adequately control the disease can be achieved using an initial dose secretiveness 5 mg / kg secretiveness day in achieving a satisfactory effect, the dose should gradually reduce and if possible, cyclosporin should be abolished; in case of recurrence secretiveness be conducted repeated treatment, despite the fact that treatment duration of 8 weeks may be sufficient to clean the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. The main pharmaco-therapeutic effects: does antimicrobial action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic processes in the body were found. Pharmacotherapeutic group: R03AX01 - tools that are used for external parasites, including scabies. Indications for use drugs: treatment of postoperative and traumatic wounds, complicated by purulent here wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions.